Table 2.
Incidence rates of MAT events
| Outcomes | PBSC donors |
BM donors |
Rate ratio (95% CI) | P value | ||||
|---|---|---|---|---|---|---|---|---|
| Person-years | No. of events | Incidence rate∗ (95% CI) | Person-years | No. of events | Incidence rate∗ (95% CI) | |||
| Myeloid | 118 712 | 3 | 2.53 (0.82-7.84) | 72 641 | 3 | 4.13 (1.33-12.8) | 0.61 (0.12-3.03) | .55 |
| Lymphoid | 118 649 | 17 | 14.33 (8.91-23.05) | 72 572 | 10 | 13.78 (7.41-25.61) | 1.04 (0.48-2.27) | .92 |
| Other malignancies | 116 213 | 535 | 460.36 (423.0-501.0) | 70 553 | 368 | 521.59 (471.1-577.6) | 0.88 (0.77-1.00) | .05 |
| Autoimmune | 116 566 | 449 | 385.19 (351.2-422.4) | 71 269 | 262 | 367.62 (325.8-414.9) | 1.03 (0.89-1.21) | .66 |
| Thrombosis | 117 977 | 156 | 132.23 (113.0-154.7) | 72 172 | 95 | 131.63 (107.7-160.9) | 1.01 (0.78-1.30) | .95 |
CI, Confidence interval
∗
Incidence rate per 100 000 person-years.